(Q38820169)

6 September 2017

title

miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4. (English)

1 reference

6 September 2017

Ling-yan Lv

1

1 reference

6 September 2017

Yu-zhi Wang

2

1 reference

6 September 2017

Qian Zhang

3

1 reference

6 September 2017

Hong-rui Zang

4

1 reference

6 September 2017

Xing-jie Wang

5

1 reference

6 September 2017

publication date

11 November 2015

1 reference

Cell Biochemistry & Function

6 September 2017

published in

1 reference

6 September 2017

volume

33

1 reference

6 September 2017

issue

8

1 reference

6 September 2017

page(s)

534-540

1 reference

The enigmatic epidemiology of nasopharyngeal carcinoma

6 September 2017

cites work

1 reference

An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation

21 January 2018

1 reference

Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea.

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

microRNAs as Developmental Regulators

21 January 2018

1 reference

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

21 January 2018

1 reference

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

21 January 2018

1 reference

MicroRNA signatures in human cancers

21 January 2018

1 reference

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2

21 January 2018

1 reference

MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma

21 January 2018

1 reference

miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.

21 January 2018

1 reference

MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma

21 January 2018

1 reference

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

21 January 2018

1 reference

MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression

21 January 2018

1 reference

Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis

21 January 2018

1 reference

MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.

21 January 2018

1 reference

MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer

21 January 2018

1 reference

Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme

21 January 2018

1 reference

miR-124 radiosensitizes human glioma cells by targeting CDK4.

21 January 2018

1 reference

MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways

21 January 2018

1 reference

Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CBF.3152

1 reference

6 September 2017

1 reference